Advertisement

Topics

FDA Eyeing Other PD-1/L1 Drugs With Clinical Hold On Keytruda Myeloma Trials

15:23 EDT 31 Aug 2017 | SCRIP

Merck previously disclosed the clinical hold on the three trials at the beginning of July; FDA says its announcement is...

      

Related Stories

 

Original Article: FDA Eyeing Other PD-1/L1 Drugs With Clinical Hold On Keytruda Myeloma Trials

NEXT ARTICLE

More From BioPortfolio on "FDA Eyeing Other PD-1/L1 Drugs With Clinical Hold On Keytruda Myeloma Trials"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...